Estradiol transdermal HRT

Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.

Estradiol transdermal HRTOestrogen replacement

Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.

Estradiol transdermal HRT: indication-specific regimens
Indication	Dose	Route	Frequency	Duration / preparation	Maximum	Monitoring / cautions
Menopausal symptoms after individual assessment; intact uterus also needs adequate progestogen Novartis / emcchecked	One patch releasing 50 micrograms per 24 hours	Transdermal	Replace twice weekly, every 3–4 days	Use the lowest effective dose with regular benefit/risk review; review new bleeding promptly · Apply to clean dry intact abdominal skin, never the breasts; rotate sites, avoid waistline and do not cut the patch. Remove the old patch when replacing The dose is a RELEASE RATE per 24 hours; it does not mean applying a new patch every day. HRT is not contraception.	This starting example is 50 micrograms/24 h; higher strengths require reassessment and proportionate progestogen	Monitor Symptom response, bleeding, BP and changing breast/VTE/liver risk Contraindications / cautions Unexplained genital bleeding, known/suspected oestrogen-dependent cancer, active/prior VTE, arterial thrombosis or active liver disease; pregnancy/breastfeeding

Pregnancy safety

Not indicated in pregnancy

Lactation

Not indicated during breastfeeding